• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Genetics

ALS/MND can affect families in different ways. In about 90% of cases, there is only one person in a family with ALS/MND. This is called sporadic ALS/MND. In about 10% of cases, more than one person in the same family is affected. This is known as hereditary or familial ALS/MND and may be linked to a change in a gene that runs in a family.

For some families, understanding hereditary ALS/MND may be an important next step. It can help explain why the condition affects more than one person in the same family and why symptoms may differ across family members. It may also help families understand what information they may want to explore next.

Even in cases of sporadic ALS/MND, meaning there is no known family history, genetics may still be relevant. This is because a genetic change may still be present even when ALS/MND appears to affect only one person in a family. This is one reason information about genetics may be useful to a wider group of people and families.

The materials below support different needs and different levels of interest. They include brief explanations, visual resources, and additional information for those who want to learn more about genetics in ALS/MND.


Starting with the basics

To better understand genetics, it can be helpful to start with the basics. The visual explainers below introduce the genome, DNA, genes, and chromosomes, and provide a simple foundation for the rest of this section.

  • What is your genome? ( PDF): This infographic introduces the genome and shows how DNA, genes, chromosomes, RNA, and proteins are connected. It explains how genetic information is stored and used, helping build a foundation for genetics in ALS/MND.
  • Introduction to Genetics (PDF): This infographic introduces genetics and how genetic changes can be passed through families in different ways. It helps explain why some are affected, others are unaffected carriers, and why hereditary conditions look different in each family.

Understanding genetics in ALS/MND

The visual explainers below build on these basic concepts and focus more directly on how genetics may relate to ALS/MND and why it may matter for individuals and families.

  • Why is genetics relevant to ALS/MND? (PDF): This infographic shows how family history and genetic causes do not always fit simple categories. It explains the difference between hereditary and sporadic ALS/MND, varied inheritance patterns, and that a genetic cause can be found even without clear family history.
  • Can genes affect the type of ALS/MND? (PDF): This infographic explains penetrance, which means that carrying a genetic change does not always mean a person will develop ALS/MND. It also shows that genes can lead to different types of ALS/MND across individuals.

Learn more about genetics in ALS/MND

These resources provide broader introductions to genetics and inherited ALS/MND. They may be helpful for readers who want to build on the visual explainers and explore these topics in more detail.

  • Introduction to ALS/MND Genetics (video): This Alliance webinar gives an overview of genetics in ALS/MND and the current ALS/MND landscape. It is intended to help people living with ALS/MND and their families build a basic understanding of genetics, what it may mean for them, and what options may be available.
  • Inherited MND: Introduction (webpage): This resource from the MND Association introduces inherited ALS/MND and is useful for readers wanting more after the visual explainers.
  • Familial ALS (PDF): This ALS Association booklet provides broader information on familial ALS/MND and may suit readers seeking a detailed resource.

Primary Sidebar

  • Fabio Correia, Brazil

    Fabio Correia, Brazil

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • Mahmood Anwar, UK

    Mahmood Anwar, UK

  • Camilla Heiberg Freiberg, Denmark

    Camilla Heiberg Freiberg, Denmark

  • Soledad Rodriguez, Spain

    Soledad Rodriguez, Spain

  • Mauricio Dorin, Argentina

    Mauricio Dorin, Argentina

  • Peng Yi-Wen, Taiwan

    Peng Yi-Wen, Taiwan

  • PALS and CALS, Singapore

    PALS and CALS, Singapore

  • Liam Dwyer, England

    Liam Dwyer, England

  • Emilienne Verhaegen, Belgium

    Emilienne Verhaegen, Belgium

  • Anderson Custodio Pinto, Brazil

    Anderson Custodio Pinto, Brazil

  • Dr. Shelly Hoover, USA

    Dr. Shelly Hoover, USA

  • Mike Small, UK

    Mike Small, UK

  • Claire Garry, USA

    Claire Garry, USA
    20200117_214643

  • Carlos Alberto Arango, Colombia

    Carlos Alberto Arango, Colombia

  • Rudiger Hanemann, Germany

    Rudiger Hanemann, Germany

  • Bruno Leanza Mantegna, Italy

    Bruno Leanza Mantegna, Italy

  • Alfredo Santos, Colombia

    Alfredo Santos, Colombia

  • Roy Taylor, Ireland

    Roy Taylor, Ireland
    roy

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • Ann Nicol, USA

    Ann Nicol, USA

  • Orlando Ruiz, Colombia

    Orlando Ruiz, Colombia

  • Sanjay Kumar Srivastava, India

    Sanjay Kumar Srivastava, India

  • Sam Hayden-Harler, UK

    Sam Hayden-Harler, UK

  • Alberto Baez Murillo, Colombia

    Alberto Baez Murillo, Colombia

  • Wiebke Braach, Germany

    Wiebke Braach, Germany

  • Imelda Arenas, Colombia

    Imelda Arenas, Colombia

  • Chen Chun-Chin, Malaysia

    Chen Chun-Chin, Malaysia

  • Claudette Sturk, Canada

    Claudette Sturk, Canada
    Picture2

  • Angela Jansen, Germany

    Angela Jansen, Germany

  • Shay Rishoni, Netherlands

    Shay Rishoni, Netherlands

  • Mauril Belanger, Canada

    Mauril Belanger, Canada

  • Shera Mukherjee, India

    Shera Mukherjee, India

  • Erwin Coppejans, Belgium

    Erwin Coppejans, Belgium

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Joanne Pratt, Australia

    Joanne Pratt, Australia

  • Luis Antonio Pimenta Lima, Brazil

    Luis Antonio Pimenta Lima, Brazil

  • Magdalena Ayala Rodríguez, Mexico

    Magdalena Ayala Rodríguez, Mexico

  • Barry de Reuver, Netherlands

    Barry de Reuver, Netherlands

  • Margreth Burger-Saile, Switzerland

    Margreth Burger-Saile, Switzerland

  • Bob Simonds, USA

    Bob Simonds, USA

  • Aida Trzmiel de Guterman, Argentina

    Aida Trzmiel de Guterman, Argentina

  • Xian-Zhang Niu, China

    Xian-Zhang Niu, China

  • Hanne Stenmose, Denmark

    Hanne Stenmose, Denmark

  • Jose Espinosa, Argentina

    Jose Espinosa, Argentina

  • Fayette Underwood, USA

    Fayette Underwood, USA

  • Elisabeth Zahnd, Switzerland

    Elisabeth Zahnd, Switzerland

  • Francisco Perez Palop, Spain

    Francisco Perez Palop, Spain

  • Steve Lufkin, USA

    Steve Lufkin, USA
    IMG_3993

  • Elkin Gaviria, Colombia

    Elkin Gaviria, Colombia

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login